Patrick Melvin joins oncology leadership team at INC Research

Tuesday, March 1, 2011 08:00 AM

CRO INC Research has named Patrick Melvin executive director, Oncology. He will be using his hematology/oncology trial experience for phase I first-in-man studies through pivotal global phase IV programs.

Melvin has nearly 20 years of experience in clinical drug development in hematology and oncology. He previously worked in operations, strategic planning and corporate development within the oncology business of both PPD and Premier Research. His key early-phase experience includes multiple variations of early-phase hematology/oncology trial designs, while his later-phase experience includes pivotal trial experience in the U.S., Western and Eastern Europe, Latin America and Asia-Pacific.

Share:          
CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs